Enantioselective Functionalizations of Azomethines and Alkenes
甲亚胺和烯烃的对映选择性官能化
基本信息
- 批准号:9050686
- 负责人:
- 金额:$ 28.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAlkenesAmidinesAminesAreaCarbonCarbon DioxideCatalysisChagas DiseaseChemistryChronicCollaborationsCommunicable DiseasesComplexCouplingCyclizationDevelopmentDiaminesElectronicsFundingGoalsHalogensHealthHumanHydrogen BondingImidazolinesIodineMDM2 geneMalignant NeoplasmsMeasuresMediatingMedicineMetalsMethodsNatural ProductsOxygenPharmaceutical PreparationsPopulationPreparationProductionProtonsReactionReagentResourcesStereoisomerTP53 geneTherapeutic AgentsTrypanosoma cruziVariantWorkXenograft procedureaurora kinasebasecatalystcostenantiomerimprovedinnovationmelanomamilligrammouse modelnitroalkanenutlin 3programsprotein protein interactionscaffoldsmall moleculesmall molecule therapeuticstertiary aminetherapeutic developmenttool
项目摘要
DESCRIPTION (provided by applicant): The overarching goal of this proposal is the development of new reactions, and the reagents that control them, to generate enantioenriched organic compounds. These products are valuable precursors to more elaborate small molecules that are medicinal agents and/or more complex biologically active natural products. The proposed methods specifically target the concise synthesis of secondary amines, tertiary amines, and vicinal diamines as single stereoisomers. These methods are based on the development of bis (amidine) reagents that form chiral proton complexes (a polar ionic hydrogen bond) when a strong acid is added, or when used with acidic substrates. Exploration of a new variant is also described, which contains a single amidine in close proximity to a hydrogen bond donor (polar covalent hydrogen bond) when projected from the same chiral scaffold. These studies continue the successful application of bifunctional organocatalysts to the stereocontrolled creation of structural and functional motifs that, while common, are otherwise difficult to prepare using conventional alternatives. These studies also explore an entirely new mode of activation that involves chiral Brønsted acid mediated halogen- alkene reactions. A range of innovative multicomponent coupling reactions will be developed using chiral proton catalysis as the means to control enantioselection. These studies have the potential to impact small molecule synthesis, and ultimately the development of therapeutic agents. Moreover, the methods enable the metal-free production of functionally dense, single enantiomer (and diastereomer) organic compounds.
描述(由申请人提供):本提案的总体目标是开发新反应和控制它们的试剂,以生成对映体富集的有机化合物。这些产物是更精细的小分子的有价值的前体,所述小分子是药剂和/或更复杂的生物活性天然产物。所提出的方法具体针对作为单一立体异构体的仲胺、叔胺和邻二胺的简明合成。这些方法是基于双(脒)试剂的开发,当加入强酸或与酸性底物一起使用时,双(脒)试剂形成手性质子络合物(极性离子氢键)。还描述了一种新的变体的探索,其包含从相同的手性支架投射时靠近氢键供体(极性共价氢键)的单个脒。这些研究继续成功地应用双功能有机催化剂的立体控制创建的结构和功能的图案,虽然常见的,否则难以使用常规的替代品。这些研究还探索了一种全新的活化模式,涉及手性布朗斯台德酸介导的卤素-烯烃反应。一系列创新的多组分偶联反应将开发使用手性质子催化作为手段来控制对映选择。这些研究有可能影响小分子合成,并最终影响治疗药物的开发。此外,所述方法能够无金属地生产功能致密的单一对映异构体(和非对映异构体)有机化合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Nicholas Johnston其他文献
Jeffrey Nicholas Johnston的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Nicholas Johnston', 18)}}的其他基金
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
开发镜像天然产物作为抗心律失常疗法
- 批准号:
10589858 - 财政年份:2020
- 资助金额:
$ 28.49万 - 项目类别:
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
开发镜像天然产物作为抗心律失常疗法
- 批准号:
10372134 - 财政年份:2020
- 资助金额:
$ 28.49万 - 项目类别:
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
开发镜像天然产物作为抗心律失常疗法
- 批准号:
9917405 - 财政年份:2020
- 资助金额:
$ 28.49万 - 项目类别:
New Stereoselective Reactions for Chiral Amine Synthesis
手性胺合成的新立体选择性反应
- 批准号:
8110644 - 财政年份:2009
- 资助金额:
$ 28.49万 - 项目类别:
Enantioselective Functionalizations of Azomethines and Alkenes
甲亚胺和烯烃的对映选择性官能化
- 批准号:
8697731 - 财政年份:2009
- 资助金额:
$ 28.49万 - 项目类别:
New Stereoselective Reactions for Chiral Amine Synthesis
手性胺合成的新立体选择性反应
- 批准号:
8267696 - 财政年份:2009
- 资助金额:
$ 28.49万 - 项目类别:
New Stereoselective Reactions for Chiral Amine Synthesis
手性胺合成的新立体选择性反应
- 批准号:
7817116 - 财政年份:2009
- 资助金额:
$ 28.49万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 28.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 28.49万 - 项目类别:
Operating Grants